Drug Type Small molecule drug |
Synonyms MT 2004 |
Target |
Mechanism FXR agonists(Bile acid receptor FXR agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cholestasis | Phase 2 | CN | 30 Nov 2023 | |
Chemical and Drug Induced Liver Injury | Phase 2 | CN | 10 Aug 2023 | |
Cholestatic liver disease | Phase 2 | CN | 10 Aug 2023 | |
Liver Injury | Phase 2 | CN | 10 Aug 2023 | |
MASH | IND Approval | CN | 01 Dec 2021 |